Anti-bacterial Properties of Transition Metal Complexes of Copper Metal Ion: A Mini Review

Abhay Nanda Srivastva (1. Department of Chemistry, Nitishwar Mahavidyalaya, B. R. A. Bihar University, Muzarrafpur, 842002, India; 2. University Department of Chemistry, B. R. A. Bihar University, Muzaffarpur, 842001, India)
Nisha Saxena (Department of Chemistry, M. R. M. College, L. N. Mithila University, Darbhanga, 846004, India)
Netra Pal Singh (Department of Chemistry, D. D. U. Gorakhpur University, Gorakhpur, 273009, India)
Jayant Kumar (Graduate student, Department of Zoology, Nitishwar Mahavidyalaya, B. R. A. Bihar University, Muzarrafpur, 842002, India)

Article ID: 4836

DOI: https://doi.org/10.30564/jmmr.v5i2.4836

Abstract


Bacterial infections are a major cause for impulsive deaths in human beings.Bacterial infections of the respiratory, gastrointestinal and central nervoussystem account for the majority of cases of sudden casualties. Readily availabledrugs are getting ineffective by each passing day as the mutation is veryfast in these pathogenic microbes resulting in drug resistance. The growingresistance of bacteria necessitates the development of new and effectivecompounds of desired characteristics that could bar the rapid development ofbacterial cell inside of the host body. Along with cellular resistance for clinicalantibiotics, co-bacterial infections during microbial attacks (viz. virus, fungus,protozoans etc.) also demand for some novel antibacterial drugs having highefficacy and minimal side effects on human body. These antibiotics shouldalso be compatible with remedies ongoing for core microbial infections. So,in demand of search for effective antibacterial moieties, the scope of transitionmetal complexes as drug gives a good signal against the pathogenic bacteriaby inhibiting their growth. The action of metal complexes on bacterial cellmay be due to impremiablity, enzymatic interruptions, ribosomal interactions,disturbance in the path of protein synthesis, denaturing of genetic materialsetc. inside the cell. Metals in complexes may interrupt the lipophilisity throughthe bacterial cell wall. Inclusion of metal ions in organic moieties behavingas ligand delocalize π-electrons upon the entire chelate ring and this chelationresults in overlapping of ligand orbital and partial sharing of (+)ve chargeof metal ion with donor atoms. These structural modifications in metal andorganic lone pair donor species are the supposed reasons for their enhancedantimicrobial activities against pathogenic microbes. The present reviewfocuses on the impact of recently synthesized, well characterized mono andbinuclear transition metal complexes of Cu ions that have the potential to be the drug of the decade in medicinal inorganic chemistry for treating the bacterial diseases.

Keywords


Ligands; Coordination compounds; Antimicrobial activity; Drug resistance

Full Text:

PDF

References


[1] Makovec, T., 2019. Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy. Radiology and Oncology. 53(2), 148-158. DOI: https://dx.doi.org/10.2478%2Fraon-2019-0018

[2] Alderden, R.A., Hall, M.D., Hambley, T.W., 2006. The Discovery and Development of Cisplatin. Journal of Chemical Education. 83(5), 728-734. DOI: https://doi.org/10.1021/ed083p728

[3] Abu-Dief, A.M., Mohamed, I.M.A., 2015. A review on versatile applications of transition metal complexes incorporating Schiff bases. Beni-Suef University Journal of Basic Applied Science. 4(2), 119-133. DOI: https://doi.org/10.1016/j.bjbas.2015.05.004

[4] Kawarada, H., Yoshikawa, Y., Yasui, H., et al., 2011. Synthesis and in vitro insulin-mimetic activities of zinc(II) complexes of ethyl 2,5-dihydro-4-hydroxy-5- oxo-1H-pyrrole-3-carboxylates. Metallomics. 3, 675- 679. DOI: https://doi.org/10.1039/C1MT00009H

[5] Mahdavian, M., Attar, M.M., 2009. Electrochemical behaviour of some transition metal acetylacetonate complexes as corrosion inhibitors for mild steel. Corrosion Science. 51(2), 409-414. DOI: https://doi.org/10.1016/j.corsci.2008.11.010

[6] Chakraborty, J.N., 2011. 13 -Metal-complex dyes, Editor(s): M. Clark, In Woodhead Publishing Series in Textiles, Handbook of Textile and Industrial Dyeing, Woodhead Publishing. 1, 446-465. DOI: https://doi.org/10.1533/9780857093974.2.446.

[7] Srivastva, A.N., (Ed.), 2017. Stability and Applications of Coordination Compounds. IntechOpen, London. DOI: https://doi.org/10.5772/intechopen.83186

[8] Srivastava, A.N., Panja, S., Singh, N.P., et al., 2021. Bioactive metal complexes of a Schiff base derived from 2,3-Dioxobutane, Ethane-1,2-diamine and 4-Chloro-2-formylphenol: Spectral studies and in vitro antimicrobial activity. Asian Journal of Chemistry. 33(12), 3063-3069. DOI: https://doi.org/10.14233/ajchem.2021.23478

[9] Jaafar, A., Mansour, N., Fix-Tailler, A., et al., 2022. Synthesis, Characterization, Antibacterial and Antifungal Activities Evaluation of Metal Complexes With Benzaldehyde-4-methylthiosemicarbazone Derivatives. Chemistry Select. 7(10), e202104497. DOI: https://doi.org/10.1002/slct.202104497

[10] Nandanwar, S.K., Borkar, S.B., Wijaya, B.N., et al., 2020. Cobalt(II) Benzazole Derivative Complexes: Synthesis, Characterization, Antibacterial and Synergistic Activity. Chemistry Select. 5(11), 3471-3476. DOI: https://doi.org/10.1002/slct.202000222

[11] Jones, C.J., Thornback, J.R., 2007. Medicinal Applications of Coordination Chemistry. The Royal Society of Chemistry, Cambridge, U.K. DOI: https://doi.org/10.1039/9781847557759

[12] Kumar, S., Choudhary, M., 2022. Synthesis and characterization of novel copper(ii) complexes as potential drug candidates against SARS-CoV-2 main protease. New Journal of Chemistry. 46, 4911-4926. DOI: https://doi.org/10.1039/D2NJ00283C

[13] Ali, A., Sepay, N., Afzal, M., et al., 2021. Molecular designing, crystal structure determination and in silico screening of copper(II) complexes bearing 8-hydroxyquinoline derivatives as anti-COVID-19. Bioorganic Chemistry. 110, 104772. DOI: https://doi.org/10.1016/j.bioorg.2021.104772

[14] Yousuf, I., Bashir, M., Arjmand, F., et al., 2021. Advancement of metal compounds as therapeutic and diagnostic metallodrugs: Current frontiers and future perspectives. Coordination Chemistry Review. 445, 214104. DOI: https://doi.org/10.1016/j.ccr.2021.214104

[15] Yousuf, S., Arjmand, F., Tabassum, S., 2021. Design, synthesis, ligand’s scaffold variation and structure elucidation of Cu(II) complexes; In vitro DNA binding, morphological studies and their anticancer activity. Polyhedron. 209, 115450. DOI: https://doi.org/10.1016/j.poly.2021.115450.

[16] Pelosi, G., Bisceglie, F., Bignami, F., et al., 2010. Antiretroviral activity of thiosemicarbazone metal complexes. Journal of Medicinal Chemistry. 53(24), 8765-8769. DOI: https://doi.org/10.1021/jm1007616

[17] Srivastva, A.N., Singh, N.P., Shriwastaw, C.K., 2016. In vitro antibacterial and antifungal activities of binuclear transition metal complexes of ONNO Schiff base and 5-methyl-2,6-pyrimidine-dione and their spectroscopic validation. Arabian Journal of Chemistry. 9, 48-61. DOI: https://doi.org/10.1016/j.arabjc.2014.10.004

[18] Bakale, R.P., Naik, G.N., Machakanur, S.S., et al., 2018. Structural characterization and antimicrobial activities of transition metal complexes of a hydrazone ligand. Journal of Molecular Structure. 1154, 92-99. DOI: https://doi.org/10.1016/j.molstruc.2017.10.035

[19] Devi, J., Yadav, M., Kumar, D., et al., 2019. Some divalent metal(II) complexes of salicylaldehyde-derived Schiff bases: Synthesis, spectroscopic characterization, antimicrobial and in vitro anticancer studies. Appllied Organometallic Chemistry. 33, e4693. DOI: https://doi.org/10.1002/aoc.4693

[20] Hazra, M., Dolai, T., Pandey, A., et al., 2014. Synthesis and Characterisation of Copper(II) Complexes with Tridentate NNO Functionalized Ligand: Density Function Theory Study, DNA Binding Mechanism, Optical Properties, and Biological Application. Bioinorgnic Chemistry and Applications. 1-13. DOI: https://doi.org/10.1155/2014/104046

[21] Pahontu, E., Julea, F., Rosu, T., et al., 2015. Antibacterial, antifungal and in vitro antileukemia activity of metal complexes with thiosemicarbazones. Journal of Cellular and Molecular Medicine. 19, 865-878. DOI: https://doi.org/10.1111/jcmm.12508

[22] Mishra, A.P., Mishra, R., Jain, R., et al., 2012. Synthesis of New VO(II), Co(II), Ni(II) and Cu(II) Complexes with Isatin-3-Chloro-4-Floroaniline and 2-Pyridinecarboxylidene-4-Aminoantipyrine and their Antimicrobial Studies. Mycobiology. 40, 20-26. DOI: https://doi.org/10.5941/MYCO.2012.40.1.020

[23] Kathiresan, S., Anand, T., Mugesh, S., et al., 2015. Synthesis, spectral characterization and DNA bindings of tridentate N2O donor Schiff base metal(II) complexes. Journal of Photochemistry and Photobiology B: Biology. 148, 290-301. DOI: https://doi.org/10.1016/j.jphotobiol.2015.04.016

[24] Karekal, M.R., Biradar, V., Bennikallu Hire Mathada, M., 2013. Synthesis, Characterization, Antimicrobial, DNA Cleavage, and Antioxidant Studies of Some Metal Complexes Derived from Schiff Base Containing Indole and Quinoline Moieties. Bioinorgnic Chemistry and Applications. 1-16. DOI: https://doi.org/10.1155/2013/315972

[25] Raman, N., Sakthivel, A., Pravin, N., 2014. Exploring DNA binding and nucleolytic activity of few 4-amino -antipyrine based amino acid Schiff base complexes: A comparative approach. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 125, 404-413. DOI: https://doi.org/10.1016/j.saa.2014.01.108

[26] Mahmoud, W.H., Mohamed, G.G., El-Sayed, O.Y., 2018. Coordination compounds of some transition metal ions with new Schiff base ligand derived from dibenzoyl methane. Structural characterization, thermal behavior, molecular structure, antimicrobial, anticancer activity and molecular docking studies. Appllied Organometallic Chemistry. 32, e4051. DOI: https://doi.org/10.1002/aoc.4051

[27] Chohan, Z.H., Supuran, C.T., 2005. Organometallic compounds with biologically active molecules: in vitro antibacterial and antifungal activity of some 1,1′-(dicarbohydrazono) ferrocenes and their cobalt(II), copper(II), nickel(II) and zinc(II) complexes. Appllied Organometallic Chemistry. 19, 1207-1214. DOI: https://doi.org/10.1002/aoc.944

[28] Alagha, A., Parthasarathi, L., Gaynor, D., et al., 2011. Metal complexes of cyclic hydroxamates. Synthesis and crystal structures of 3-hydroxy-2-methyl-3Hquinazolin-4-one (CHaH) and of its Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) complexes. Inorganica Chimica Acta. 368, 58-66. DOI: https://doi.org/10.1016/j.ica.2010.12.047

[29] Nandanwar, S.K., Kim, H.J., 2019. Anticancer and Antibacterial Activity of Transition Metal Complexes. Chemistry Select. 4, 1706-1721. DOI: https://doi.org/10.1002/slct.201803073

[30] Psomas, G., Kessissoglou, D.P., 2013. Quinolones and non-steroidal anti-inflammatory drugs interacting with copper(II), nickel(II), cobalt(II) and zinc(II): structural features, biological evaluation and perspectives. Dalton Transactions. 42, 6252-6276. DOI: https://doi.org/10.1039/C3DT50268F

[31] Nagender, P., Kumar, R.N., Reddy, G.M., et al., 2016. Synthesis of novel hydrazone and azole functionalized pyrazolo[3,4-b]pyridine derivatives as promising anticancer agents. Bioorganic and Medicinal Chemistry Letters. 26, 4427-4432. DOI: https://doi.org/10.1016/j.bmcl.2016.08.006

[32] Arbaoui, A., Redshaw, C., Sanchez-Ballester, N.M., et al., 2011. Bimetallic copper(II) and zinc(II)complexes of acrylic Schiff base ligands derived from amino acids. Inorganica Chimica Acta. 365, 96-102. DOI: https://doi.org/10.1016/j.ica.2010.08.043

[33] Kumar, G., Kumar, D., Devi, S., et al., 2010. Synthesis, spectral characterization and antimicrobial evaluation of Schiff base Cu(II), Ni(II) and Co(II) complexes. European Journal of Medicinal Chemistry. 45, 3056-3062. DOI: https://doi.org/10.1016/j.ejmech.2010.03.036

[34] Singh, N.P., Srivastava, A.N., 2012. Physico-chemical and biological studies of Cu(II), Co(II) and Ni(II) complexes of an N4 coordinating ligand derived from the Schiff base of diacetyl with ethylenediamine and benzoic acid. Journal of Serbian Chemical Society. 77, 627-637. DOI: https://doi.org/10.2298/JSC110412148S

[35] Chityala, V.K., Kumar, K.S., Subhashini, N.J.P., et al., 2013. Synthesis, crystal structure, spectroscopic, and biological studies on Cu(II) complexes of N,O donor dimethyl isoxazole Schiff bases. Journal of Coordination Chemistry. 66, 274-286. DOI: https://doi.org/10.1080/00958972.2012.755174

[36] Gamba, I., Mutikainen, I., Bouwman, E., et al., 2013. Synthesis and characterization of copper complexes of a tetrapyridyl ligand, and their use in the catalytic aerobic oxidation of benzyl alcohol. European Journal of Inorganic Chemistry. 115-123. DOI: https://doi.org/10.1002/ejic.201200807

[37] Evangelinou, O., Hatzidimitriou, A.G., Velali, E., et al., 2014. Mixed-ligand copper(I) halide complexes bearing 4,5-bis(diphenylphosphano)-9,9-dimethyl-xanthene and N-methylbenzothiazole-2-thione: Synthesis, structures, luminescence and antibacterial activity mediated by DNA and membrane damage. Polyhedron. 72, 122-129. DOI: https://doi.org/10.1016/j.poly.2014.02.002

[38] Singh, K., Barwa, M.S., Tyagi, P., 2066. Synthesis, characterization and biological studies of Co (II), Ni (II), Cu (II) and Zn (II) complexes with bidentate Schiff bases derived by heterocyclic ketone. European Journal of Medicinal Chemistry. 41, 147-153. DOI: https://doi.org/10.1016/j.ejmech.2005.06.006

[39] Tabassum, S., Asim, A., Arjmand, F., et al., 2012. Synthesis and characterization of copper(II) and zinc(II)-based potential chemotherapeutic compounds: their biological evaluation viz. DNA binding profile, cleavage and antimicrobial activity. European Journal of Medicinal Chemistry. 58, 308-316. DOI: https://doi.org/10.1016/j.ejmech.2012.09.051

[40] Srivastva, A.N., Singh, N.P., Shriwastaw, C.K., 2017. De novo synthesis of trivalent metal complexes with ligand derived from N1-[2-(2-Amino-ethylimino)- 1-methyl-propylidene]-ethane-1,2- diamine and 4-chloro benzoic acid: spectroscopic validation and in vitro biological studies. Research on Chemical Intermediates. 43, 3663-3675. DOI: https://doi.org/10.1007/s11164-016-2839-6

[41] Lippard, S.J., Berg, J.M., 1994. Principles of Bioinorganic Chemistry, University Science Books, Mill Valley, CA. DOI: https://doi.org/10.1016/0307-4412(95)90685-1

[42] Parveen, S., Arjmand, F., Zhang, Q., et al., 2020. Molecular docking, DFT and antimicrobial studies of Cu (II) complex as topoisomerase I inhibitor. Journal of Biomolecular Structure and Dynamics. 25, 1-14. DOI: https://doi.org/10.1080/07391102.2020.1743365

[43] Zehra, S., Tabassum, S., Arjmand, F., 2021. Biochemical pathways of copper complexes: progress over the past 5 years. Drug Discovery Today. 26(4), 1086-1096. DOI: https://doi.org/10.1016/j.drudis.2021.01.015

[44] Chopra, I., Hesse, L., O’Neill, A.J., 2022. Exploiting current understanding of antibiotic action for discovery of new drugs. Journal of Applied Microbiology. 92, 4S-15S. DOI: https://doi.org/10.1046/j.1365-2672.92.5s1.13.x

[45] Knowles, D.J.C., 1997. New strategies for antibacterial drug design. Trends in Microbiology. 5, 379-383. DOI: https://doi.org/10.1016/S0966-842X(97)01128-1

[46] Payne, D.J., Gwynn, M.N., Holmes, D.J., et al., 2007. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nature Review Drug Discovery. 6, 29-40. DOI: https://doi.org/10.1038/nrd2201

[47] Spellberg, B., Guidos, R., Gilbert, D., et al., 2008. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clinical Infectious Diseases. 46, 155-164. DOI: https://doi.org/10.1086/524891

[48] Talbot, G.H., Bradley, J., Edwards(Jr.), J.E., et al., 2006. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clinical Infectious Diseases. 42, 657-668. DOI: https://doi.org/10.1086/503200

[49] Newman, D.J., Cragg, G.M., Snader, K.M., 2000. The influence of natural products upon drug discovery. Natural Product Reports. 17, 215-234. DOI: https://doi.org/10.1039/A902202C

[50] National Center for Biotechnology Information, 2022. PubChem Compound Summary. https://pubchem.ncbi.nlm.nih.gov/.

[51] Kar, A., 2005. Medicinal Chemistry (3rd Ed.), New Age International Publishers, New Delhi, India. pp. 629-671.

[52] Meenongwa, A., Brissos, R.F., Soikum, C., et al., 2016. Effects of N, N-heterocyclic ligands on the in vitro cytotoxicity and DNA interactions of copper (II) chloride complexes from amidino-O-methylurea ligands. New Journal of Chemistry. 40(7), 5861-5876. DOI: https://doi.org/10.1039/C5NJ03439F

[53] Kuzovlev, A.S., Volkova, D.A., Parfenova, I.V., et al., 2020. (i) halide and palladium (ii) chloride complexes of 4-thioxo [1, 3, 5] oxadiazocines: synthesis, structure and antibacterial activity. New Journal of Chemistry. 44(19), 7865-7875. DOI: https://doi.org/10.1039/C9NJ05958J

[54] Kumar, M., Kumar, G., Dadure, K.M., et al., 2019. Copper (II) complexes based on levofloxacin and 2N-donor ligands: synthesis, crystal structures and in vitro biological evaluation. New Journal of Chemistry. 43(38), 15462-15481. DOI: https://doi.org/10.1039/C9NJ03178B

[55] Gur’eva, Y.A., Zalevskaya, O.A., Shevchenko, O.G., et al., 2022. Copper (ii) complexes with terpene derivatives of ethylenediamine: synthesis, and antibacterial, antifungal and antioxidant activity. RSC Advances. 12(15), 8841-8851. DOI: https://doi.org/10.1039/D2RA00223J

[56] Shebl, M., El-ghamry, M.A., Khalil, S.M.E., et al., 2014. Mono- and binuclear copper(II) complexes of new hydrazone ligands derived from 4,6-diacetylresorcinol: Synthesis, spectral studies and antimicrobial activity. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 126, 232-241. DOI: https://doi.org/10.1016/j.saa.2014.02.014

[57] Santiago, P.H.O., Santiago, M.B., Martins, C.H.G., et al., 2020. Copper(II) and zinc(II) complexes with Hydrazone: Synthesis, crystal structure, Hirshfeld surface and antibacterial activity. Inorganica Chimica Acta. 508, 119632. DOI: https://doi.org/10.1016/j.ica.2020.119632

[58] Geeta, B., Shravankumar, K., Muralidhar Reddy, P., et al., 2010. Binuclear cobalt(II), nickel(II), copper(II) and palladium(II) complexes of a new Schiffbase as ligand: Synthesis, structural characterization, and antibacterial activity. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 77(4), 911-915. DOI: https://doi.org/10.1016/j.saa.2010.08.004

[59] Zhu, C.Y., Li, Y.T., Wu, Z.Y., et al., 2007. Synthesis, crystal structure and antibacterial activity of a new binuclear copper(II) complex with N , N ′- bis ( N -hydroxyethylaminopropyl)oxamido as a bridging ligand. Journal of Coordination Chemistry. 60(4), 465- 472. DOI: https://doi.org/10.1080/00958970600880831

[60] Gaber, A., Refat, M.S., Belal, A.A., et al., 2021. New Mononuclear and Binuclear Cu(II), Co(II), Ni(II), and Zn(II) Thiosemicarbazone complexes with potential biological activity: Antimicrobial and molecular docking study. Molecules. 26(8), 2288. DOI: https://doi.org/10.3390/molecules26082288


Refbacks

  • There are currently no refbacks.
Copyright © 2022 Authors


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.